Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Preparation and physicochemical characterization of naproxen-PLGA nanoparticles.

Javadzadeh Y, Ahadi F, Davaran S, Mohammadi G, Sabzevari A, Adibkia K.

Colloids Surf B Biointerfaces. 2010 Dec 1;81(2):498-502. doi: 10.1016/j.colsurfb.2010.07.047.

PMID:
20719477
2.

Naproxen-eudragit RS100 nanoparticles: preparation and physicochemical characterization.

Adibkia K, Javadzadeh Y, Dastmalchi S, Mohammadi G, Niri FK, Alaei-Beirami M.

Colloids Surf B Biointerfaces. 2011 Mar;83(1):155-9. doi: 10.1016/j.colsurfb.2010.11.014.

PMID:
21130612
3.

Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis.

Adibkia K, Siahi Shadbad MR, Nokhodchi A, Javadzedeh A, Barzegar-Jalali M, Barar J, Mohammadi G, Omidi Y.

J Drug Target. 2007 Jul;15(6):407-16.

PMID:
17613659
4.

The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles.

Ozturk K, Caban S, Kozlu S, Kadayifci E, Yerlikaya F, Capan Y.

Pharmazie. 2010 Sep;65(9):665-9.

PMID:
21038843
5.

Design and optimization of NSAID loaded nanoparticles.

Sashmal S, Mukherjee S, Ray S, Thakur RS, Ghosh LK, Gupta BK.

Pak J Pharm Sci. 2007 Apr;20(2):157-62.

PMID:
17416573
6.
8.
9.

Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system.

Mohammadi G, Nokhodchi A, Barzegar-Jalali M, Lotfipour F, Adibkia K, Ehyaei N, Valizadeh H.

Colloids Surf B Biointerfaces. 2011 Nov 1;88(1):39-44. doi: 10.1016/j.colsurfb.2011.05.050.

PMID:
21752610
10.
11.

The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.

Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A.

Colloids Surf B Biointerfaces. 2009 Nov 1;74(1):340-9. doi: 10.1016/j.colsurfb.2009.08.003.

PMID:
19717287
12.
13.

Development and characterization of naproxen-chitosan solid systems with improved drug dissolution properties.

Mura P, Zerrouk N, Mennini N, Maestrelli F, Chemtob C.

Eur J Pharm Sci. 2003 May;19(1):67-75.

PMID:
12729863
14.
15.

Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.

Budhian A, Siegel SJ, Winey KI.

Int J Pharm. 2007 May 24;336(2):367-75.

PMID:
17207944
16.

[Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].

Miao LF, Yang J, Huang CL, Song CX, Zeng YJ, Chen LF, Zhu WL.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Aug;30(4):491-7. Chinese.

18.

Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.

Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP.

Nanomedicine. 2007 Dec;3(4):246-57.

PMID:
18068091
19.

The effect of different grades of PLGA on characteristics of microspheres encapsulated with cyclosporine A.

Malaekeh-Nikouei B, Sajadi Tabassi SA, Jaafari MR.

Curr Drug Deliv. 2006 Oct;3(4):343-9.

PMID:
17076635
20.

Relationship between the solution thermodynamic properties of naproxen in organic solvents and its release profiles from PLGA microspheres.

Aragón DM, Rosas JE, Martínez F.

J Microencapsul. 2013;30(3):218-24. doi: 10.3109/02652048.2012.717114.

PMID:
23369165
Items per page

Supplemental Content

Support Center